Context Dependent Roles for RB-E2F Transcriptional Regulation in Tumor Suppression

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Feb 1

PMID 30703085

Authors

Michael J Thwaites

Matthew J Cecchini

Daniel T Passos

Komila Zakirova

Frederick A Dick

Affiliations

Soon will be listed here.

Abstract

RB-E2F transcriptional control plays a key role in regulating the timing of cell cycle progression from G1 to S-phase in response to growth factor stimulation. Despite this role, it is genetically dispensable for cell cycle exit in primary fibroblasts in response to growth arrest signals. Mice engineered to be defective for RB-E2F transcriptional control at cell cycle genes were also found to live a full lifespan with no susceptibility to cancer. Based on this background we sought to probe the vulnerabilities of RB-E2F transcriptional control defects found in Rb1R461E,K542E mutant mice (Rb1G) through genetic crosses with other mouse strains. We generated Rb1G/G mice in combination with Trp53 and Cdkn1a deficiencies, as well as in combination with KrasG12D. The Rb1G mutation enhanced Trp53 cancer susceptibility, but had no effect in combination with Cdkn1a deficiency or KrasG12D. Collectively, this study indicates that compromised RB-E2F transcriptional control is not uniformly cancer enabling, but rather has potent oncogenic effects when combined with specific vulnerabilities.

References

Williams B, Remington L, Albert D, Mukai S, Bronson R, Jacks T . Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet. 1994; 7(4):480-4. DOI: 10.1038/ng0894-480. View

Manning A, Benes C, Dyson N . Whole chromosome instability resulting from the synergistic effects of pRB and p53 inactivation. Oncogene. 2013; 33(19):2487-94. PMC: 3884049. DOI: 10.1038/onc.2013.201. View

Kruiswijk F, Labuschagne C, Vousden K . p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol. 2015; 16(7):393-405. DOI: 10.1038/nrm4007. View

Thwaites M, Cecchini M, Dick F . Analyzing RB and E2F during the G1-S transition. Methods Mol Biol. 2014; 1170:449-61. DOI: 10.1007/978-1-4939-0888-2_24. View

Van den Heuvel S, Harlow E . Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 1993; 262(5142):2050-4. DOI: 10.1126/science.8266103. View

Deng C, Zhang P, Harper J, Elledge S, Leder P . Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 1995; 82(4):675-84. DOI: 10.1016/0092-8674(95)90039-x. View

Ji P, Jiang H, Rekhtman K, Bloom J, Ichetovkin M, Pagano M . An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol Cell. 2004; 16(1):47-58. DOI: 10.1016/j.molcel.2004.09.029. View

Brugarolas J, Bronson R, Jacks T . p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J Cell Biol. 1998; 141(2):503-14. PMC: 2148461. DOI: 10.1083/jcb.141.2.503. View

Vervoorts J, Luscher B . Post-translational regulation of the tumor suppressor p27(KIP1). Cell Mol Life Sci. 2008; 65(20):3255-64. PMC: 11131874. DOI: 10.1007/s00018-008-8296-7. View

10.

Jackson E, Willis N, Mercer K, Bronson R, Crowley D, Montoya R . Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 2001; 15(24):3243-8. PMC: 312845. DOI: 10.1101/gad.943001. View

11.

Bertoli C, Skotheim J, de Bruin R . Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol. 2013; 14(8):518-28. PMC: 4569015. DOI: 10.1038/nrm3629. View

12.

Buttitta L, Edgar B . Mechanisms controlling cell cycle exit upon terminal differentiation. Curr Opin Cell Biol. 2007; 19(6):697-704. PMC: 2700000. DOI: 10.1016/j.ceb.2007.10.004. View

13.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

14.

Sherr C, McCormick F . The RB and p53 pathways in cancer. Cancer Cell. 2002; 2(2):103-12. DOI: 10.1016/s1535-6108(02)00102-2. View

15.

Thwaites M, Cecchini M, Passos D, Welch I, Dick F . Interchangeable Roles for E2F Transcriptional Repression by the Retinoblastoma Protein and p27KIP1-Cyclin-Dependent Kinase Regulation in Cell Cycle Control and Tumor Suppression. Mol Cell Biol. 2016; 37(2). PMC: 5214858. DOI: 10.1128/MCB.00561-16. View

16.

Sadasivam S, DeCaprio J . The DREAM complex: master coordinator of cell cycle-dependent gene expression. Nat Rev Cancer. 2013; 13(8):585-95. PMC: 3986830. DOI: 10.1038/nrc3556. View

17.

Kareta M, Gorges L, Hafeez S, Benayoun B, Marro S, Zmoos A . Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis. Cell Stem Cell. 2014; 16(1):39-50. PMC: 4389904. DOI: 10.1016/j.stem.2014.10.019. View

18.

Coschi C, Ishak C, Gallo D, Marshall A, Talluri S, Wang J . Haploinsufficiency of an RB-E2F1-Condensin II complex leads to aberrant replication and aneuploidy. Cancer Discov. 2014; 4(7):840-53. DOI: 10.1158/2159-8290.CD-14-0215. View

19.

Cecchini M, Amiri M, Dick F . Analysis of cell cycle position in mammalian cells. J Vis Exp. 2012; (59). PMC: 3462567. DOI: 10.3791/3491. View

20.

Ku S, Rosario S, Wang Y, Mu P, Seshadri M, Goodrich Z . Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science. 2017; 355(6320):78-83. PMC: 5367887. DOI: 10.1126/science.aah4199. View